You are on page 1of 15

Inception with the Name of Allah the most

Merciful and the most Beneficent.


Tuberculosis
Presented By: Salman Afzal
Class No: 09 (E)
Session: 2012-2017
Outline:

Introduction
Clinical Situation
Etiology
Pathophysiology
Clinical
Features
Treatment Protocol


Introduction:

 Most Prevalent
 Communicable
 Infectious Disease
 Involves Lungs
Clinical Situation

Ancient Disease >>> 17,000 Years.


Listed in Top 10 killer Infectious Diseases.
World Wide Pandemic.
Leading Cause of Death >>> HIV infected
people.
In Pakistan >>> approx. 70,000 Deaths.
270,000 people >>> fall Sick annually.
Etiology:

Mycobacterium Tuberculosis
Unusual:
An outer waxy coat
Acid Fast Bacilli
Aerobic
Non-Motile
Highly Contagious
Pathophysiology:
 Exposure or Inhalation (How you get exposed?)
 Tubercle Bacilli invasions → Apices of Lungs.
 Broncho-Pneumonia develops ,
 Exudation & Infiltration of Neutrophil granulocytes.
 Neutrophils are replaced by Macrophages.
 Macrophages then Ingest the Bacilli.
 Bacterial cell wall + Macrophage >>>Bacilli Replication
Pathophysiology Conti……

 Necrotic Degeneration Occur,


 Production of Cavities filled with cheese like mass of
 Tubercle Bacilli
 Dead WBC,s
 Necrotic Lung tissue
 Drainage of Necrotic Material → Into
Tracheobronchial Tree,
 Eruption of coughing
 Formation of Lesions
Clinical Features:

 Productive Cough
 Weight Loss
 Fatigue
 Fever
 Night Sweats
Treatment:

 Regimen for Treating T.B.


 Intensive Phase ( 2 months)
 Continuation Phase ( 4 or 7 months)
 Total 6-9 months of treatment
Intensive Phase:

 Daily
 Isoniazid (INH)
 Rifampicin
 Pyrazinamide
 Ethambutol

 for 8 weeks approx. 56 doses.


Continuation Phase:

 Daily
 Isoniazid (INH)
 Rifampicin

 For 18 weeks approx. 126 doses.


Direct Observed Therapy (DOT).

 National T.B treatment guideline recommendation.


 What is DOT?
 Designatedindividual > provides T.B. drugs > watches the
patient swallow every dose.
 Why Use DOT?
 Can’t predict
 People from all social classes
 Prevent T.B. from spreading
 Decreases risk of drug resistance
Direct Observed Therapy (DOT)………
 Who Deliver DOT?
 Nurse or trained Health care worker.
 HOW the DOT administered?
 DOT include,
 Delivering Medications
 Checking Side effects
 Watching Patient Swallow medication
 Documenting Visits
 Answering Questions
Thank You

You might also like